Romano, Paschoalina
Agena, Fabiana
de Almeida Rezende Ebner, Pérsio
Massakazu Sumita, Nairo
Kamada Triboni, Ana Heloísa
Ramos, Fernanda
dos Santos Garcia, Márcio
Coelho Duarte, Nilo José
Brambate Carvalhinho Lemos, Francine
Zocoler Galante, Nelson
David-Neto, Elias
Article History
First Online: 18 September 2018
Compliance with Ethical Standards
:
: The authors declare no conflict of interest.
: The nEverOld study was supported by an unrestricted grant from Novartis Pharma Brazil as an Investigator Initiated Trial. Novartis had no role in the study design, data collection, and analysis, the decision to publish, or the preparation of the manuscript.
: All procedures used in this study were in accordance with the 1964 Declaration of Helsinki and its subsequent amendments. The study protocol was approved by the Institutional Review Board of the Hospital das Clínicas (CAPPESQ # 26423). Clinical Trials.gov identifier: NCT 01631058.
: Written informed consent was obtained from all of the patients included in this study, or their caregivers.